Items where Subject is "F150 - Medicinal chemistry"

A

Alvariño, Rebeca, Alfonso, Amparo, Tabudravu, Jioji ORCID: 0000-0002-6930-6572, González-Jartín, Jesús, Al Maqbali, Khalid, Elhariry, Marwa, Vieytes, Mercedes R. and Botana, Luis M. (2024) Psammaplin A and Its Analogs Attenuate Oxidative Stress in Neuronal Cells through Peroxisome Proliferator-Activated Receptor γ Activation. Journal of Natural Products, 87 (4). pp. 1187-1196. ISSN 0163-3864

D

Davies, Matthew P, Benitez, Rocio, Perez, Concepcion, Jakupovic, Sven, Welsby, Philip John ORCID: 0000-0002-2110-8198, Rzepecka, Klaudia Magdalena, Alder, Jane Elizabeth ORCID: 0000-0003-4463-0349, Davidson, Colin ORCID: 0000-0002-8180-7943, Martinez, Ana et al (2021) Structure-Based Design of Potent Selective Nanomolar Type-II Inhibitors of Glycogen Synthase Kinase-3β. Journal of Medicinal Chemistry, 64 (3). pp. 1497-1509. ISSN 0022-2623

Dennison, Sarah Rachel ORCID: 0000-0003-4863-9607, Harris, Frederick and Phoenix, David A. (2017) Investigations into the potential anticancer activity of Maximin H5. Biochimie, 137 . pp. 29-34. ISSN 0300-9084

E

Elsawy, Mohamed ORCID: 0000-0003-3964-2150, Martin, Lorraine, Tikhonova, Irina G. and Walker, Brian (2013) Solid phase synthesis of Smac/DIABLO-derived peptides using a ‘Safety-Catch’ resin: Identification of potent XIAP BIR3 antagonists. Bioorganic and Medicinal Chemistry, 21 (17). pp. 5004-5011. ISSN 0968-0896

Elsawy, Mohamed ORCID: 0000-0003-3964-2150, Tikhonova, Irina, Martin, Lorraine and Walker, Brian (2015) Smac-Derived Aza-Peptide As an Aminopeptidase-Resistant XIAP BIR3 Antagonist. Protein and Peptide Letters, 22 (9). pp. 836-843. ISSN 0929-8665

I

Ingham, Oliver (2020) Preparation, stability testing and in vitro antiproliferative determination of ester and amide derivatives of Temozolomide. Doctoral thesis, University of Central Lancashire.

K

Khan, Zahra Rafiqa, Welsby, Philip J., Stasik, Izabela ORCID: 0000-0002-7756-4731 and Hayes, Joseph ORCID: 0000-0002-7745-9616 (2024) Discovery of Potent Multikinase Type-II Inhibitors Targeting CDK5 in the DFG-out Inactive State with Promising Potential against Glioblastoma. Journal of Medicinal Chemistry, 67 (9). pp. 7539-7552. ISSN 0022-2623

M

Mourya, Atul, Shubhra, Bajwa, Ashish, Singh, Kamalinder ORCID: 0000-0001-7325-0711, Pandey, Manisha, Singh, Shashi Bala and Madan, Jitender (2022) Potential of Phytomolecules in Sync with Nanotechnology to Surmount the Limitations of Current Treatment Options in the Management of Osteoarthritis. Mini Reviews in Medicinal Chemistry .

P

Paraskevaidi, Maria, Allsop, David, Karim, Salman, Martin, Francis L ORCID: 0000-0001-8562-4944 and Crean, Stjohn ORCID: 0000-0001-9336-8549 (2020) Diagnostic Biomarkers for Alzheimer's Disease Using Non-Invasive Specimens. Journal of Clinical Medicine, 9 (6). p. 1673.

S

Sherer, Christopher ORCID: 0000-0002-6422-9870 (2017) A multidisciplinary investigation into the design, synthesis and evaluation of a novel class of anti-glioblastoma drug fragments. Doctoral thesis, University of Central Lancashire.

Sherer, Christopher ORCID: 0000-0002-6422-9870, Prabhu, Saurabh, Adams, David R, Hayes, Joseph ORCID: 0000-0002-7745-9616, Rowther, Farzana, Tolaymat, Ibrahim, Warr, Tracy and Snape, Timothy James ORCID: 0000-0003-2766-4491 (2018) Towards identifying potent new hits for glioblastoma. MedChemComm, 9 (11). pp. 1850-1861. ISSN 2040-2503

Sherer, Christopher ORCID: 0000-0002-6422-9870, Tolaymat, Ibrahim, Rowther, Farzana, Warr, Tracy and Snape, Timothy James ORCID: 0000-0003-2766-4491 (2017) Preliminary SAR on indole-3-carbinol and related fragments reveals a novel anticancer lead compound against resistant glioblastoma cells. Bioorganic & Medicinal Chemistry Letters, 27 (7). pp. 1561-1565. ISSN 0960-894X